BEBoris Epel

Boris Epel

*This is an algorithmically generated author record based on publicly available information.

Boris Epel has a total of 120 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Advanced Inversion Recovery Single Point Imaging for High Spatial Resolution and Quantitative Oxygen Imaging

    by Boris Epel, Irene Canavesi, Mrignayani Kotecha

    Purpose: The partial pressure of oxygen (pO 2 ) in tissue is a tightly regulated physiological quantity. Hypoxia is a hallmark of many diseases, and changes in tissue pO 2 underline critical developmental, metabolic, and physiological processes. Electron paramagnetic resonance oxygen imaging (EPROI) has emerged as the most precise technique to image pO 2 in vitro and in vivo. EPROI uses linear relationship between the relaxation rates (R 1 or R 2 ) of the spin probe OXO71 and pO 2 . Methods: The current gold standard for EPROI is inversion recovery electron spin echo (IRESE) sequence with radial k ‐space acquisition scheme, which is fast, provides high pO 2 resolution using T 1 imaging, but suffers from low spatial resolution, especially at higher oxygen concentrations. The other method, single‐point imaging (SPI), which uses Cartesian k ‐space acquisition scheme and free‐induction decay (FID) readout, provides higher spatial resolution but has lower signal‐to‐noise ratio (SNR) and lower pO 2 accuracy, especially for T 2 * imaging. In this work, we introduce advanced inversion‐recovery single‐point imaging (AIR‐SPI), which combines inversion‐recovery SPI (IR‐SPI) with multi‐point FID averaging in the spatial domain. We evaluate the performance of AIR‐SPI in phantoms and in vivo imaging of a fibrosarcoma (FSA) tumor in a mouse leg. Results: We demonstrate 2–8‐fold SNR improvement and higher spatial resolution for AIR‐SPI compared to IR‐SPI and IRESE, especially for high oxygen concentrations. We also demonstrate higher pO 2 precision for AIR‐SPI. Conclusions: AIR‐SPI offers improvements in image SNR, spatial, and oxygen resolution over all existing EPR oxygen imaging methods, without increasing imaging time. Importantly, it uses smaller RF power than echo‐based methods, which is crucial for scaling EPROI to human applications.

  • Trityl OXO71 Pharmacokinetics and Distribution in Rhesus Macaques

    by Christopher D. Kroenke, Irene Canavesi, Jenna N. Castro, Joshua A. Karpf, Raman Khurana, Megan M. Holloway, Mitasha S. Palha, Eric A. Legenzov, Nathan P. Crilly, Boris Epel, et al.

    Purpose: Electron paramagnetic resonance oxygen imaging ( EPROI ) techniques have the ability to quantify the partial pressure of oxygen ( pO 2 ), in vivo, through quantitative measurement of T 1e maps of the trityl radical, OXO71 . OXO71 ‐based EPROI has seen several applications in small animal imaging studies, but translation to humans will benefit from optimization of EPROI using large animal subjects that are anatomically and physiologically similar to humans. The goal of this study was to characterize pharmacokinetics and tissue distribution following an intravenous administration of OXO71 in rhesus macaques. Methods: A 92 μmol/kg OXO71 dose, equivalent to doses used in studies with other animal species, was administered as a bolus injection over a 10‐min period in 3 animals. Plasma and urine were sampled over the subsequent 2 h. A second equivalent dose was then rapidly administered, animals were euthanized, and OXO71 distribution was assessed in harvested tissues by EPR imaging. Results: Pharmacokinetics of plasma OXO71 determined by EPR spectroscopy showed biphasic clearance, characterized by distinct initial and terminal half‐lives of 12.4 ± 1.2 min and 67.7 ± 8.9 min, respectively. Some variability in trityl concentration was observed between organs, but appreciable concentration was found for all tissues except the brain. Conclusion: No adverse physiological effects of the infusions were observed, consistent with a low toxicity of OXO71. These findings indicate EPROI using OXO71 is safe in primates, and provide information related to the dose and time constraints for performing EPROI in other large animal species including humans.


  • Accelerated EPR imaging using deep learning denoising

    by Irene Canavesi, Navin Viswakarma, Boris Epel, Alan McMillan, Mrignayani Kotecha

    Purpose: Trityl OXO71‐based pulse electron paramagnetic resonance imaging (EPRI) is an excellent technique to obtain partial pressure of oxygen (pO 2 ) maps in tissues. In this study, we used deep learning techniques to denoise 3D EPR amplitude and pO 2 maps. Methods: All experiments were performed using a 25 mT EPR imager, JIVA‐25®. The MONAI implementation of four neural networks (autoencoder, Attention UNet, UNETR, and UNet) was tested, and the best model (UNet) was then enhanced with joint bilateral filters (JBF). The training dataset was comprised of 227 3D images (56 in vivo and 171 in vitro), 159 images for training, 45 for validation, and 23 for testing. UNet with 1, 2, and 3 JBF layers was tested to improve image SNR, focusing on multiscale structural similarity index measure and edge sensitivity preservation. The trained algorithm was tested using acquisitions with 15, 30, and 150 averages in vitro with a sealed deoxygenated OXO71 phantom and in vivo with fibrosarcoma tumors grown in a hind leg of C3H mice. Results: We demonstrate that UNet with 2 JBF layers (UNet+JBF2) provides the best outcome. We demonstrate that using the UNet+JBF2 model, the SNR of 15‐shot amplitude maps provides higher SNR compared to 150‐shot pre‐filter maps, both in phantoms and in tumors, therefore, allowing 10‐fold accelerated imaging. We demonstrate that the trained algorithm improves SNR in pO 2 maps. Conclusions: We demonstrate the application of deep learning techniques to EPRI denoising. Higher SNR will bring the EPRI technique one step closer to clinics.


  • Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

    by Gabriela Dziurman, Aleksandra Bienia, Aleksandra Murzyn, Bartosz Płóciennik, Julia Kozik, Grzegorz Szewczyk, Małgorzata Szczygieł, Martyna Krzykawska-Serda, Boris Epel, Howard J. Halpern, et al.

    The precise and real-time measurement of oxygen partial pressure (pO2) brings valuable information in many pathologies, including cancer. Low tumor pO2 (i.e., hypoxia) is connected to tumor aggressiveness and poor response to therapy. The quantification of tumor pO2 allows the evaluation of treatment effectiveness. Electron Paramagnetic Resonance Imaging (EPRI), particularly Pulse EPRI, has emerged as an advanced three-dimensional (3D) method of assessing tissue oxygenation in vivo. This innovation was enabled by the technological developments in EPR (Electron Paramagnetic Resonance) and the application of the water-soluble oximetric spin probes from the triaryl family, offering fast and sensitive oxygenation data. The relaxation time of the spin probe (T1 and/or T2) provides accurate information about pO2 in selected voxels. Human glioblastoma LN229 tumors were grown in the interscapular fad pad of BALB/c nude mice. Ultrasound (US) imaging was used as a reference for tumor anatomical information. To image tissue pO2, the animals were placed in a fixed position in the animal bed with fiducials, enabling registration between the imaging modalities. After the OX071 contrast agent was administered, EPRI was performed, followed by US B-mode. Because of the low spin probe toxicity, the procedure can be repeated during tumor growth or treatment. Following imaging, the registration process was carried out using software written in MATLAB. Ultimately, the hypoxic fraction can be calculated for a specific tumor, and the histogram of pO2 tissue distribution can be compared over time. EPRI combined with ultrasound is an excellent tool for oxygen mapping of tumors in the preclinical setting.


  • Composite spin probes with adjustable oxygen sensitivity for pulse electron paramagnetic resonance imaging

    by Irene Canavesi, Navin Viswakarma, Raman Khurana, Boris Epel, Periannan Kuppusamy, Mark David Pagel, Mrignayani Kotecha

    Purpose: Solid crystalline spin probes, such as lithium phthalocyanine (LiPc) and lithium octa‐n‐butoxynaphthalocyanine (LiNc‐BuO), allow repeated oxygen measurement using electron paramagnetic resonance (EPR). Due to their short relaxation times, their use for pulse EPR oxygen imaging is limited. In this study, we developed and tested a new class of solid composite spin probes that modified the relaxation rates R1 and R2 of LiPc or LiNc‐BuO probes, which allowed pO2 measurements in the full dynamic (0–760 torr) range.Methods: The composite probes were developed by embedding LiPc or LiNc‐BuO with bonewax, beeswax, or petroleum jelly. All experiments were performed using a 25‐mT EPR imager, JIVA‐25®. A selected composite probe, LiPc‐BW5 (LiPc + 5‐times bonewax), was tested for its in vivo stability and robustness using oxygen‐enhanced EPR oxygen imaging. As another application, a LiPc‐BW5‐based marker was tested to outline the SCC7 tumor in a C3H mouse.Results: The composite probes showed an increased oxygen measurement range compared with unaltered probes. The in vivo experiments with LiPc‐BW5 showed the stability of the probes for repeated oxygen imaging up to 4 weeks of measurements. The in vivo pO2 at the subcutaneous site changed from 26.1 ± 1.9 torr to 118.9 ± 1.9 torr when the breathing gas was changed from 21% O2 to 100% O2. The use of LiPc‐BW5 as a fiducial marker showed its use in outlining the tumor boundaries.Conclusions: We developed a new class of robust and versatile solid composite probes with adjustable oxygen sensitivity that allows pO2 imaging in the broad dynamic range.


  • Open Access

    Author Correction: Nondestructive, longitudinal, 3D oxygen imaging of cells in a multi-well plate using pulse electron paramagnetic resonance imaging

    by Safa Hameed, Navin Viswakarma, Greta Babakhanova, Carl G. Simon, Boris Epel, Mrignayani Kotecha


  • Open Access

    Nondestructive, longitudinal, 3D oxygen imaging of cells in a multi-well plate using pulse electron paramagnetic resonance imaging

    by Safa Hameed, Navin Viswakarma, Greta Babakhanova, Carl G. Simon, Boris Epel, Mrignayani Kotecha

    The use of oxygen by cells is an essential aspect of cell metabolism and a reliable indicator of viable and functional cells. Here, we report partial pressure oxygen (pO2) mapping of live cells as a reliable indicator of viable and metabolically active cells. For pO2 imaging, we utilized trityl OX071-based pulse electron paramagnetic resonance oxygen imaging (EPROI), in combination with a 25 mT EPROI instrument, JIVA-25™, that provides 3D oxygen maps with high spatial, temporal, and pO2 resolution. To perform oxygen imaging in an environment-controlled apparatus, we developed a novel multi-well-plate incubator-resonator (MWIR) system that could accommodate 3 strips from a 96-well strip-well plate and image the middle 12 wells noninvasively and simultaneously. The MWIR system was able to keep a controlled environment (temperature at 37 °C, relative humidity between 70%–100%, and a controlled gas flow) during oxygen imaging and could keep cells alive for up to 24 h of measurement, providing a rare previously unseen longitudinal perspective of 3D cell metabolic activities. The robustness of MWIR was tested using an adherent cell line (HEK-293 cells), a nonadherent cell line (Jurkat cells), a cell-biomaterial construct (Jurkat cells seeded in a hydrogel), and a negative control (dead HEK-293 cells). For the first time, we demonstrated that oxygen concentration in a multi-well plate seeded with live cells reduces exponentially with the increase in cell seeding density, even if the cells are exposed to incubator-like gas conditions. For the first time, we demonstrate that 3D, longitudinal oxygen imaging can be used to assess cells seeded in a hydrogel. These results demonstrate that MWIR-based EPROI is a versatile and robust method that can be utilized to observe the cell metabolic activity nondestructively, longitudinally, and in 3D. This approach may be useful for characterizing cell therapies, tissue-engineered medical products, and other advanced therapeutics.


  • Oxygen Imaging of a Rabbit Tumor Using a Human-Sized Pulse Electron Paramagnetic Resonance Imager

    by Boris Epel, Navin Viswakarma, Subramanian V. Sundramoorthy, Nitin J. Pawar, Mrignayani Kotecha

    Purpose Spatial heterogeneity in tumor hypoxia is one of the most important factors regulating tumor growth, development, aggressiveness, metastasis, and affecting treatment outcome. Most solid tumors are known to have hypoxia or low oxygen levels (pO2 ≤10 torr). Electron paramagnetic resonance oxygen imaging (EPROI) is an emerging oxygen mapping technology. EPROI utilizes the linear relationship between the relaxation rates of the injectable OX071 trityl spin probe and the partial oxygen pressure (pO2). However, most of the EPROI studies have been limited to mouse models of solid tumors because of the instrument-size limitations. The purpose of this work was to develop a human-sized 9-mT (250 MHz resonance frequency, 60 cm bore size) pulse EPROI instrument and evaluate its performance with rabbit VX-2 tumor oxygen imaging. Methods A New Zealand white rabbit with a 3.2-cm VX-2 tumor in the calf muscle was imaged using the human-sized EPROI instrument and a 2.25-in. ID volume coil. The animal received a ~8-min intravenous injection of OX071 (5.2 mL total volume at 72 mM concentration) and, after 75 min, an intratumoral injection (120 μL total at 5 mM OX071 concentration) and underwent EPROI. At the end of the experiments, MRI was performed using a preclinical 9.4-T MRI system to outline the tumor boundaries. Results For the first time, a human-sized pulse EPROI instrument with a 60-cm bore size/250-MHz frequency was built and evaluated using rabbit tumor oxygen imaging. For the first time, the systemic IV injection of the oxygen-sensitive trityl OX071 spin probe was used for an animal of this size. The resulting EPROI image from the IV injection showed complete tumor coverage. The image obtained after intratumoral injection showed localized coverage in the upper lobe of the tumor, demonstrating the need for improved intratumoral injection protocol. Conclusions This study demonstrates the performance of the world’s first human-sized pulse EPROI instrument. It also demonstrates that the EPROI of larger animals can be performed using the systemic injection of a manageable amount of the spin probe. This brings EPROI one step closer to clinical applications in cancer therapies. Oxygen imaging is a platform technology, and the instrument and techniques developed here will also be useful for other clinical applications.


  • A Preclinical Positron Emission Tomography (PET) and Electron-Paramagnetic-Resonance-Imaging (EPRI) Hybrid System: PET Detector Module

    by Heejong Kim, Yuexuan Hua, Boris Epel, Subramanian Sundramoorthy, Howard Halpern, Chin-Tu Chen, Chien-Min Kao

    We report the design and experimental validation of a compact positron emission tomography (PET) detector module (DM) intended for building a preclinical PET and electron-paramagnetic-resonance-imaging hybrid system that supports submillimeter image resolution and high-sensitivity, whole-body animal imaging. The DM is eight detector units (DUs) in a row. Each DU contains $12\times 12$ lutetium–yttrium oxyorthosilicate (LYSO) crystals having a 1.05-mm pitch read by $4\times 4$ silicon photomultipliers (SiPMs) having a 3.2-mm pitch. A small-footprint, highly multiplexing readout employing only passive electronics is devised to produce six outputs for the DM, including two outputs derived from SiPM cathodes for determining event time and active DU and four outputs derived from SiPM anodes for determining energy and active crystal. Presently, we have developed two DMs that are $1.28\times 10.4$ cm2 in extent and approximately 1.8 cm in thickness, with their outputs sampled at 0.7GS/s and analyzed offline. For both DMs, our results show successfully discriminated DUs and crystals. With no correction for SiPM nonlinearity, the average energy resolution for crystals in a DU ranges from 14% to 16%. While not needed for preclinical imaging, the DM may support 300–400-ps time-of-flight resolution.


  • In Vivo Partial Oxygen Pressure Assessment in Subcutaneous and Intraperitoneal Sites Using Imaging of Solid Oxygen Probe

    by Navin Viswakarma, Eliyas Siddiqui, Sonny Patel, Safa Hameed, Wilson Schreiber, Harold M. Swartz, Boris Epel, Mrignayani Kotecha

    The purpose of this study was to assess the natural pO2 of subcutaneous (SC) and intraperitoneal (IP) sites in mice to determine their relative suitability as sites for placement of implants. The pO2 measurements were performed using oxygen imaging of solid probes using lithium phthalocyanine (LiPc) as the oxygen sensitive material. LiPc is a water-insoluble crystalline probe whose spin-lattice and spin-spin relaxation rates (R1 and R2) are sensitive to the local oxygen concentration. To facilitate direct in vivo oxygen imaging, we prepared a solid probe containing encapsulated LiPc crystals in polydimethylsiloxane (PDMS), an oxygen-permeable and bioinert polymer. While LiPc-PDMS or similar probes have been used in repeated spectroscopic or average oxygen measurements using continuous wave (CW) electron paramagnetic resonance (EPR) since the late 1990s and now have advanced to clinical applications, they have not been used for pulse EPR oxygen imaging. One LiPc-PDMS probe of 2 mm diameter and 10 mm length was implanted in subcutaneous or intraperitoneal sites (left or right side) in each animal. The pO2 imaging of implanted LiPc-PDMS probes was performed weekly for six weeks using O2M’s preclinical 25 mT oxygen imager, JIVA-25, using the pulse inversion recovery electron spin echo (IRESE) method. At week 6, the probes were recovered, and histological examinations were performed. We report here, first-ever solid probe oxygen imaging of implanted devices and pO2 assessment of subcutaneous and intraperitoneal sites.